Prelude Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRLD and other ETFs, options, and stocks.About PRLD
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines.
CEOKrishna Vaddi
CEOKrishna Vaddi
Employees131
Employees131
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2016
Founded2016
Employees131
Employees131
PRLD Key Statistics
Market cap109.41M
Market cap109.41M
Price-Earnings ratio-0.90
Price-Earnings ratio-0.90
Dividend yield—
Dividend yield—
Average volume405.90K
Average volume405.90K
High today$1.56
High today$1.56
Low today$1.43
Low today$1.43
Open price$1.56
Open price$1.56
Volume291.42K
Volume291.42K
52 Week high$4.22
52 Week high$4.22
52 Week low$0.6101
52 Week low$0.6101
Stock Snapshot
Prelude Therapeutics(PRLD) stock is priced at $1.45, giving the company a market capitalization of 109.41M. It carries a P/E multiple of -0.90.
During the trading session on 2025-12-06, Prelude Therapeutics(PRLD) shares reached a daily high of $1.56 and a low of $1.43. At a current price of $1.45, the stock is +1.8% higher than the low and still -7.1% under the high.
Trading volume for Prelude Therapeutics(PRLD) stock has reached 291.42K, versus its average volume of 405.9K.
The stock's 52-week range extends from a low of $0.61 to a high of $4.22.
The stock's 52-week range extends from a low of $0.61 to a high of $4.22.
People also own
Based on the portfolios of people who own PRLD. This list is generated using Robinhood data, and it’s not a recommendation.